Data suggest liver experts should take care when prescribing novel antiviral HCV drugs

Data presented at the International Liver Congress highlight the fact that new novel antiviral compounds for the treatment of hepatitis C virus (HCV) must be prescribed and monitored by experts and specialists to ensure resistance is minimised.1,2,3,4,5,6

Read the whole article on Physorg

More from Physorg